ClinicalTrials.Veeva

Menu
R

Red Oak Psychiatry Associates | Houston, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Cariprazine
PRC-063
SPD489
SHP465
Fluoxetine
Aticaprant
BMS-820836
L1-79
Levomilnacipran
Seltorexant

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 19 total trials

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder. (3112 Ped BPD)

Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population and 1.8% of the pediatric population in the United S...

Enrolling
Bipolar I Disorder
Depression
Drug: Placebo
Drug: Cariprazine

The purpose of this study is to evaluate the long-term safety and tolerability of cariprazine in the treatment of pediatric participants with schizop...

Active, not recruiting
Bipolar I Disorder
Schizophrenia
Drug: Cariprazine Flexible Dose

Trial sponsors

AbbVie logo
R
Shire logo
Janssen (J&J Innovative Medicine) logo
Bristol-Myers Squibb (BMS) logo
Forest Laboratories logo
N
N
S
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems